[ET Net News Agency, 26 August 2026] UBS lowered the target price for RemeGen (09995) to HKD132.5 from HKD135.2 and maintained the "buy" rating.
The research house said it fine-tunes estimates following the Q226 results. (rc)
The research house said it fine-tunes estimates following the Q226 results. (rc)